Human enterotoxigenic <i>Escherichia coli</i> (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic <i>Escherichia coli</i> and <i>Shigella</i>

D David P. Buckley M Marjahan Akhtar M Mahima Thapa (Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine) A Aaron Schmitz (Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine) J Jackson Turner (Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine) T Tim J. Vickers (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine) N Nazia Khatoon (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine) M M. Hasanul Kaisar (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine) J Jonathan A. Coggin (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine) D Debayan Ganguli (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine) A Alaullah Sheikh (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine) R Renee M. Laird (Military Relevant Bacterial Diseases Department, Naval Medical Research Command) F Frédéric Poly (Military Relevant Bacterial Diseases Department, Naval Medical Research Command) C Chad K. Porter (Translational and Clinical Research Department, Naval Medical Research Command) F Fernando Ruiz-Perez (Department of Pediatrics, University of Virginia School of Medicine) M Mark J. Miller (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine) F Fahima Chowdhury (Mucosal Immunology and Vaccinology Unit, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh) T Tafiqur R. Bhuiyan (Mucosal Immunology and Vaccinology Unit, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh) F Firdausi Qadri S Sergio Trillo-Muyo (Department of Medical Biochemistry and Cell Biology, University of Gothenburg) B Brendan Dolan (Department of Medical Biochemistry and Cell Biology, University of Gothenburg) S Sjoerd van der Post (Department of Medical Biochemistry and Cell Biology, University of Gothenburg) A Ali Ellebedy (Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine) Z Zachary T. Berndsen (Department of Biochemistry, University of Missouri Columbia) J James M. Fleckenstein (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine)

Abstract

Enterotoxigenic Escherichia coli (ETEC) and Shigella are the most common bacterial diarrheal pathogens among young children of low-middle income regions. Enteric pathogens must overcome formidable host defenses, including the protective barrier formed by intestinal mucus. ETEC produce a virulence protein called EatA, a member of the Serine Protease Autotransporter of the Enterobacteriae (SPATE) family, where the secreted passenger domain (EatA p ) specifically degrades MUC2, the major mucus secreted by goblet cells of the human intestine. Notably, some Shigella spp., as well as other diarrheagenic E. coli pathovars, secrete homologues of EatA known as SepA, and Pic. Here, we demonstrate that EatA, SepA, and Pic are functionally redundant MUC2 mucinases and that recombinant monoclonal antibodies (mAbs) derived from plasmablasts of ETEC-infected humans can inhibit MUC2 degradation by all three proteases. We present cryo-EM structures of EatA and the related SPATE proteins, SepA, and Pic, complexed to fragment antigen-binding portions of these mAbs to demonstrate that those targeting a core β-helix epitope shared by all three SPATE molecules broadly neutralize the capacity to degrade MUC2. These mAbs effectively prevent MUC2 degradation by each SPATE as well as mucus penetration by ETEC, Shigella flexneri , and Pic-producing enteroaggregative E. coli (EAEC). We anticipate that these studies could facilitate rational design of vaccines that broadly protect against major enteric pathogens by targeting a shared virulence feature.

Article Details

Volume / Issue Vol. 123, Issue 25
Published June 23, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (25)

D

David P. Buckley

M

Marjahan Akhtar

M

Mahima Thapa

Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine

A

Aaron Schmitz

Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine

J

Jackson Turner

Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine

T

Tim J. Vickers

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine

N

Nazia Khatoon

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine

M

M. Hasanul Kaisar

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine

J

Jonathan A. Coggin

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine

D

Debayan Ganguli

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine

A

Alaullah Sheikh

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine

R

Renee M. Laird

Military Relevant Bacterial Diseases Department, Naval Medical Research Command

F

Frédéric Poly

Military Relevant Bacterial Diseases Department, Naval Medical Research Command

C

Chad K. Porter

Translational and Clinical Research Department, Naval Medical Research Command

F

Fernando Ruiz-Perez

Department of Pediatrics, University of Virginia School of Medicine

M

Mark J. Miller

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine

F

Fahima Chowdhury

Mucosal Immunology and Vaccinology Unit, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh

T

Tafiqur R. Bhuiyan

Mucosal Immunology and Vaccinology Unit, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh

F

Firdausi Qadri

S

Sergio Trillo-Muyo

Department of Medical Biochemistry and Cell Biology, University of Gothenburg

B

Brendan Dolan

Department of Medical Biochemistry and Cell Biology, University of Gothenburg

S

Sjoerd van der Post

Department of Medical Biochemistry and Cell Biology, University of Gothenburg

A

Ali Ellebedy

Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine

Z

Zachary T. Berndsen

Department of Biochemistry, University of Missouri Columbia

J

James M. Fleckenstein

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine